Éxito de vacuna contra melanoma impulsa a Moderna y Merck
A recent press release announced a significant scientific advancement, though no specific data on survival rate improvements were provided. If confirmed, this breakthrough could represent a historic milestone.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)